subject:(Drug prescription)

University of Illinois – Urbana-Champaign

1. Mutyala, Bala. Epidemiology of prescription drug abuse in Illinois high school students.

Degree: PhD, 0349, 2013, University of Illinois – Urbana-Champaign

► Prescription drug abuse has reached epidemic proportions and trends indicate that the number of adolescents who abuse these drugs will continue to increase. Every adolescent… (more)

Subjects/Keywords: Prescription Drug Abuse

Record Details Similar Records Cite « Share

❌

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6^th Edition):

Mutyala, B. (2013). Epidemiology of prescription drug abuse in Illinois high school students. (Doctoral Dissertation). University of Illinois – Urbana-Champaign. Retrieved from http://hdl.handle.net/2142/44778

Chicago Manual of Style (16^th Edition):

Mutyala, Bala. “Epidemiology of prescription drug abuse in Illinois high school students.” 2013. Doctoral Dissertation, University of Illinois – Urbana-Champaign. Accessed February 28, 2021. http://hdl.handle.net/2142/44778.

MLA Handbook (7^th Edition):

Mutyala, Bala. “Epidemiology of prescription drug abuse in Illinois high school students.” 2013. Web. 28 Feb 2021.

Vancouver:

Mutyala B. Epidemiology of prescription drug abuse in Illinois high school students. [Internet] [Doctoral dissertation]. University of Illinois – Urbana-Champaign; 2013. [cited 2021 Feb 28]. Available from: http://hdl.handle.net/2142/44778.

Council of Science Editors:

Mutyala B. Epidemiology of prescription drug abuse in Illinois high school students. [Doctoral Dissertation]. University of Illinois – Urbana-Champaign; 2013. Available from: http://hdl.handle.net/2142/44778

University of North Texas

2. Carey, Caitlyn. Anxiety Sensitivity and Non-Medical Prescription Drug Use among Adolescents.

Degree: 2020, University of North Texas

URL: https://digital.library.unt.edu/ark:/67531/metadc1707265/

► Research suggests that non-medical prescription drug (NMPD) use is becoming increasingly prevalent, particularly among adolescents. A critical step towards developing effective intervention efforts requires identifying… (more)

Subjects/Keywords: adolescents; anxiety sensitivity; AS; nonmedical prescription drug use; NMPD; NMPD use; NMPDU; prescription drug use; prescription drug misuse

Record Details Similar Records Cite « Share

❌

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6^th Edition):

Carey, C. (2020). Anxiety Sensitivity and Non-Medical Prescription Drug Use among Adolescents. (Thesis). University of North Texas. Retrieved from https://digital.library.unt.edu/ark:/67531/metadc1707265/

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16^th Edition):

Carey, Caitlyn. “Anxiety Sensitivity and Non-Medical Prescription Drug Use among Adolescents.” 2020. Thesis, University of North Texas. Accessed February 28, 2021. https://digital.library.unt.edu/ark:/67531/metadc1707265/.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7^th Edition):

Carey, Caitlyn. “Anxiety Sensitivity and Non-Medical Prescription Drug Use among Adolescents.” 2020. Web. 28 Feb 2021.

Vancouver:

Carey C. Anxiety Sensitivity and Non-Medical Prescription Drug Use among Adolescents. [Internet] [Thesis]. University of North Texas; 2020. [cited 2021 Feb 28]. Available from: https://digital.library.unt.edu/ark:/67531/metadc1707265/.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Carey C. Anxiety Sensitivity and Non-Medical Prescription Drug Use among Adolescents. [Thesis]. University of North Texas; 2020. Available from: https://digital.library.unt.edu/ark:/67531/metadc1707265/

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Penn State University

3. Nam, Young Hee. Prescription Drug Policies and Health Care: Studies on Medicare Part D Program, State Prescription Drug Monitoring Programs, and Off-label Prescribing Practices.

Degree: 2014, Penn State University

URL: https://submit-etda.libraries.psu.edu/catalog/22830

► This dissertation investigated three prescription drug policy areas, aiming to fill in the gap in the research toward reforming health care in a positive direction:… (more)

▼ This dissertation investigated three prescription drug policy areas, aiming to fill in the gap in the research toward reforming health care in a positive direction: (1) Medicare Part D program, (2) state prescription drug monitoring programs (PDMPs), and (3) off-label prescribing practices. The Medicare Part D program study examined Part D’s effects on health outcomes and Medicare spending for Parts A and B among Part D beneficiaries who previously lacked prescription drug coverage, using Medicare Current Beneficiary Survey (MCBS) Cost and Use files for 2004-2007, which are combined with Medicare claims and other administrative data, and a difference-in-differences model, estimating Part D’s treatment effects between 2005 and 2007. The results showed that Part D benefits did not have statistically significant effects on health outcomes and Medicare Parts A and B spending among the study population. In subpopulation analysis, people who previously had hypertension showed slightly, but significantly, decreased general health status and increased Medicare spending for home health agency services. The second study on PDMPs examined PDMPs’ effects in reducing drug overdose mortality rates in the United States during 1999-2010. The main data used are (1) de-identified individual-level mortality data obtained from the National Center for Health Statistics (NCHS) and (2) bridged-race population estimates data produced by the U.S. Census Bureau in collaboration with NCHS. The PDMP effects on drug overdose mortality rates were estimated using three different fixed effects models. The results suggested that PDMPs had little effect in reducing drug overdose mortality rates and might be related to unintended consequences, such as increased drug overdose deaths from illegal or unspecified drugs. The third study on off-label prescribing of drugs aimed to investigate individuals’ understanding, experience, and preferences on off-label prescribing of drugs from the perspective of patient-centered care, employing concurrent, embedded mixed methods. The primary quantitative and qualitative data were collected through a survey, on-line and off-line, among community-dwelling senior citizens age 60 and older residing in a county in Pennsylvania. The study found that an absolute majority of individuals (96 percent of the respondents) wanted to be informed of off-label prescription, and the reasons included: to make informed decision; to determine the existence and the level of scientific evidence supporting the off-label drug use; to have a partnership with physicians in their treatment; and because of their belief that making informed decisions is a patient’s right. Advisors/Committee Members: Dennis G Shea, Dissertation Advisor/Co-Advisor, Dennis G Shea, Committee Chair/Co-Chair, Pamela Farley Short, Committee Member, John Raymond Moran Jr., Committee Member, Douglas L Leslie, Committee Member.

Subjects/Keywords: Prescription drug policies; Medicare Part D; PDMPs; Off-label prescription

Record Details Similar Records Cite « Share

❌

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6^th Edition):

Nam, Y. H. (2014). Prescription Drug Policies and Health Care: Studies on Medicare Part D Program, State Prescription Drug Monitoring Programs, and Off-label Prescribing Practices. (Thesis). Penn State University. Retrieved from https://submit-etda.libraries.psu.edu/catalog/22830

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16^th Edition):

Nam, Young Hee. “Prescription Drug Policies and Health Care: Studies on Medicare Part D Program, State Prescription Drug Monitoring Programs, and Off-label Prescribing Practices.” 2014. Thesis, Penn State University. Accessed February 28, 2021. https://submit-etda.libraries.psu.edu/catalog/22830.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7^th Edition):

Nam, Young Hee. “Prescription Drug Policies and Health Care: Studies on Medicare Part D Program, State Prescription Drug Monitoring Programs, and Off-label Prescribing Practices.” 2014. Web. 28 Feb 2021.

Vancouver:

Nam YH. Prescription Drug Policies and Health Care: Studies on Medicare Part D Program, State Prescription Drug Monitoring Programs, and Off-label Prescribing Practices. [Internet] [Thesis]. Penn State University; 2014. [cited 2021 Feb 28]. Available from: https://submit-etda.libraries.psu.edu/catalog/22830.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Nam YH. Prescription Drug Policies and Health Care: Studies on Medicare Part D Program, State Prescription Drug Monitoring Programs, and Off-label Prescribing Practices. [Thesis]. Penn State University; 2014. Available from: https://submit-etda.libraries.psu.edu/catalog/22830

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

4. Darmon, David. Les déterminants de la prescription médicamenteuse en médecine générale : The determinants of drug prescription in general practice.

Degree: Docteur es, Épidemiologie. Santé publique. Recherche sur les services de santé, 2014, Université Claude Bernard – Lyon I

URL: http://www.theses.fr/2014LYO10318

► La prescription de médicaments s'accompagne de bénéfices en santé mais aussi de conséquences iatrogéniques, économiques, environnementales et écologiques. Elle tient une place centrale dans la… (more)

▼ La prescription de médicaments s'accompagne de bénéfices en santé mais aussi de conséquences iatrogéniques, économiques, environnementales et écologiques. Elle tient une place centrale dans la relation entre le patient et le médecin. En médecine générale en France, 78 % à 90 % des consultations aboutiraient à une prescription médicamenteuse versus 72 % en Allemagne et 43 % aux Pays-Bas. Le médicament est un produit complexe soumis à des logiques industrielles et de santé publique contradictoires. Sa prescription est l'aboutissement d'une décision médicale qui tient compte, dans le cadre de l'evidence-based-medicine, des données de la science, de l'expérience du médecin et des choix du patient. D'autres déterminants peuvent influencer la prescription médicamenteuse : certaines caractéristiques des maladies, des patients, des médecins et du système de soin. Afin d'identifier ces déterminants, nous avons mené une revue systématique de la littérature pour rechercher les facteurs associés au nombre de médicaments prescrits en médecine générale. Puis, à partir de l'étude épidémiologique nationale ECOGEN, nous avons identifié les facteurs liés à la prescription médicamenteuse en médecine générale en France. Pour étudier plus précisément la prescription de médicaments chez les patients atteints de maladies chroniques, nous avons mené une étude épidémiologique évaluant les facteurs associés à la prescription d'antibiotiques et d'anxiolytiques/hypnotiques aux patients asthmatiques en médecine générale en France et en Italie. Enfin, nous avons étudié la place des fonctionnalités liées à la prescription médicamenteuse dans les logiciels médicaux en France. La revue de la littérature a montré que les déterminants du nombre de médicaments prescrits en médecine générale étaient souvent liés à l'existence d'une maladie chronique, aux caractéristiques sociodémographiques des patients (personnes âgées, femmes, faible statut socioéconomique et faible niveau d'éducation) et aux caractéristiques de travail du médecin tel que le nombre de consultations par jour. L'étude épidémiologique réalisée en médecine générale en France a montré qu'un médicament était plus fréquemment prescrit aux femmes (OR : 1,12 [1,04-1,20]) et aux individus âgés de plus de 60 ans (OR : 1,35 [1,20-1,53]) ou de moins de 15 ans (OR : 1,51 [1,29-1,78]. Les médecins recevant les visiteurs de l'industrie pharmaceutique étaient aussi plus susceptibles de prescrire un médicament (OR : 1,19 [1,01-1,41]). L'étude comparant l'Italie à la France a montré que les généralistes français prescrivaient plus d'anxiolytiques/hypnotiques (17.8% vs. 6.9%, p<0.0001) mais moins d'antibiotiques (37.1% vs. 42.2%, p<0.00001) que les généralistes italiens aux patients asthmatiques. Cette étude a aussi montré qu'en France comme en Italie, les femmes asthmatiques avaient plus souvent une prescription d'antibiotiques (OR : 1.5 [1.3-1.7]) et d'anxiolytiques/hypnotiques (OR : 1.8[1.5-2.1]) que les hommes asthmatiques. Enfin, l'étude des logiciels de consultation des médecins généralistes… Advisors/Committee Members: Letrilliart, Laurent (thesis director).

Subjects/Keywords: Prescription; Médecine générale; Médicaments; Prescription; General practice; Drug; 610

Record Details Similar Records Cite « Share

❌

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6^th Edition):

Darmon, D. (2014). Les déterminants de la prescription médicamenteuse en médecine générale : The determinants of drug prescription in general practice. (Doctoral Dissertation). Université Claude Bernard – Lyon I. Retrieved from http://www.theses.fr/2014LYO10318

Chicago Manual of Style (16^th Edition):

Darmon, David. “Les déterminants de la prescription médicamenteuse en médecine générale : The determinants of drug prescription in general practice.” 2014. Doctoral Dissertation, Université Claude Bernard – Lyon I. Accessed February 28, 2021. http://www.theses.fr/2014LYO10318.

MLA Handbook (7^th Edition):

Darmon, David. “Les déterminants de la prescription médicamenteuse en médecine générale : The determinants of drug prescription in general practice.” 2014. Web. 28 Feb 2021.

Vancouver:

Darmon D. Les déterminants de la prescription médicamenteuse en médecine générale : The determinants of drug prescription in general practice. [Internet] [Doctoral dissertation]. Université Claude Bernard – Lyon I; 2014. [cited 2021 Feb 28]. Available from: http://www.theses.fr/2014LYO10318.

Council of Science Editors:

Darmon D. Les déterminants de la prescription médicamenteuse en médecine générale : The determinants of drug prescription in general practice. [Doctoral Dissertation]. Université Claude Bernard – Lyon I; 2014. Available from: http://www.theses.fr/2014LYO10318

Nelson Mandela Metropolitan University

5. Dranitsaris, George. Development of a value based pricing index for new drugs in metastatic colorectal cancer.

Degree: Faculty of Health Sciences, 2012, Nelson Mandela Metropolitan University

URL: http://hdl.handle.net/10948/d1009310

► Background: Worldwide, prices for cancer drugs have been under downward pressure where several governments have mandated price cuts of branded and generic products. A better… (more)

▼ Background: Worldwide, prices for cancer drugs have been under downward pressure where several governments have mandated price cuts of branded and generic products. A better alternative to mandated price cuts would be the estimation of a launch price based on drug performance, cost effectiveness and a country’s ability to pay. In this study, the development of a global pricing index for new drugs that encompasses all of these attributes in patients with metastatic colorectal cancer (mCRC) is described. Methods: A pharmacoeconomic model was developed to simulate clinical outcomes in mCRC patients receiving chemotherapy with the addition of a “new drug” that improves survival by 1.4, 3 and 6 months. Cost and health state utility data were obtained from cancer centers and oncology nurses (total n=112) in Canada (n=24), Spain (n=24), India (n=24), South Africa (n=16) and Malaysia (n=24). A price per dose was estimated for each survival increment using a target value threshold of three times the per capita gross domestic product (GDP) for each country, as recommended by the World Health Organisation (WHO). Multivariable analysis was then used to develop the pricing index, which considers survival benefit, per capita GDP and income dispersion as measured by the Gini coefficient as predictor variables. Results: Higher survival benefits were associated with elevated drug prices, especially in wealthier countries such as Canada and Spain. For a nation like Argentina with a per capita GDP of 15,000 and a Gini coefficient of 51, it is estimated that for a drug which provides a 4 month survival benefit in mCRC, the value based price would be US 630 per dose. In contrast, the same drug in a wealthier country like Norway could command a price of US 2,775 and still be considered cost effective according to the WHO criteria. Conclusions: A global pricing index was presented that can be used to estimate a value based price in different countries for new drugs in mCRC. The application of this index to estimate a price based on cost effectiveness would be a good starting point for opening dialogue between the key stakeholders and a better alternative to governments’ mandated price cuts.

Subjects/Keywords: Drug – Prices; Prescription pricing; Pharmaceutical industry – Prices

Record Details Similar Records Cite « Share

❌

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6^th Edition):

Dranitsaris, G. (2012). Development of a value based pricing index for new drugs in metastatic colorectal cancer. (Thesis). Nelson Mandela Metropolitan University. Retrieved from http://hdl.handle.net/10948/d1009310

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16^th Edition):

Dranitsaris, George. “Development of a value based pricing index for new drugs in metastatic colorectal cancer.” 2012. Thesis, Nelson Mandela Metropolitan University. Accessed February 28, 2021. http://hdl.handle.net/10948/d1009310.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7^th Edition):

Dranitsaris, George. “Development of a value based pricing index for new drugs in metastatic colorectal cancer.” 2012. Web. 28 Feb 2021.

Vancouver:

Dranitsaris G. Development of a value based pricing index for new drugs in metastatic colorectal cancer. [Internet] [Thesis]. Nelson Mandela Metropolitan University; 2012. [cited 2021 Feb 28]. Available from: http://hdl.handle.net/10948/d1009310.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Dranitsaris G. Development of a value based pricing index for new drugs in metastatic colorectal cancer. [Thesis]. Nelson Mandela Metropolitan University; 2012. Available from: http://hdl.handle.net/10948/d1009310

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Universidade do Rio Grande do Norte

6. Dantas, Tayne Anderson Cortez. A propaganda de medicamentos voltados à clínica obstétrica e/ou ginecológica e sua influência sobre a prescrição .

Degree: 2012, Universidade do Rio Grande do Norte

URL: http://repositorio.ufrn.br/handle/123456789/13473

► INTRODUCTION: Drug advertisement stimulates self-medication and irrational use of medicines, especially when it starts to interfere in the prescription. Monitoring advertisements, as well as the… (more)

Subjects/Keywords: Medicamentos. Propaganda. Prescrição.; Drug. Advertisement. Prescription.

Record Details Similar Records Cite « Share

❌

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6^th Edition):

Dantas, T. A. C. (2012). A propaganda de medicamentos voltados à clínica obstétrica e/ou ginecológica e sua influência sobre a prescrição . (Thesis). Universidade do Rio Grande do Norte. Retrieved from http://repositorio.ufrn.br/handle/123456789/13473

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16^th Edition):

Dantas, Tayne Anderson Cortez. “A propaganda de medicamentos voltados à clínica obstétrica e/ou ginecológica e sua influência sobre a prescrição .” 2012. Thesis, Universidade do Rio Grande do Norte. Accessed February 28, 2021. http://repositorio.ufrn.br/handle/123456789/13473.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7^th Edition):

Dantas, Tayne Anderson Cortez. “A propaganda de medicamentos voltados à clínica obstétrica e/ou ginecológica e sua influência sobre a prescrição .” 2012. Web. 28 Feb 2021.

Vancouver:

Dantas TAC. A propaganda de medicamentos voltados à clínica obstétrica e/ou ginecológica e sua influência sobre a prescrição . [Internet] [Thesis]. Universidade do Rio Grande do Norte; 2012. [cited 2021 Feb 28]. Available from: http://repositorio.ufrn.br/handle/123456789/13473.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Dantas TAC. A propaganda de medicamentos voltados à clínica obstétrica e/ou ginecológica e sua influência sobre a prescrição . [Thesis]. Universidade do Rio Grande do Norte; 2012. Available from: http://repositorio.ufrn.br/handle/123456789/13473

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Universidade do Rio Grande do Norte

7. Dantas, Tayne Anderson Cortez. A propaganda de medicamentos voltados à clínica obstétrica e/ou ginecológica e sua influência sobre a prescrição .

Degree: 2012, Universidade do Rio Grande do Norte

URL: http://repositorio.ufrn.br/handle/123456789/13473

► INTRODUCTION: Drug advertisement stimulates self-medication and irrational use of medicines, especially when it starts to interfere in the prescription. Monitoring advertisements, as well as the… (more)

Subjects/Keywords: Medicamentos. Propaganda. Prescrição.; Drug. Advertisement. Prescription.

Record Details Similar Records Cite « Share

❌

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6^th Edition):

Dantas, T. A. C. (2012). A propaganda de medicamentos voltados à clínica obstétrica e/ou ginecológica e sua influência sobre a prescrição . (Masters Thesis). Universidade do Rio Grande do Norte. Retrieved from http://repositorio.ufrn.br/handle/123456789/13473

Chicago Manual of Style (16^th Edition):

Dantas, Tayne Anderson Cortez. “A propaganda de medicamentos voltados à clínica obstétrica e/ou ginecológica e sua influência sobre a prescrição .” 2012. Masters Thesis, Universidade do Rio Grande do Norte. Accessed February 28, 2021. http://repositorio.ufrn.br/handle/123456789/13473.

MLA Handbook (7^th Edition):

Dantas, Tayne Anderson Cortez. “A propaganda de medicamentos voltados à clínica obstétrica e/ou ginecológica e sua influência sobre a prescrição .” 2012. Web. 28 Feb 2021.

Vancouver:

Dantas TAC. A propaganda de medicamentos voltados à clínica obstétrica e/ou ginecológica e sua influência sobre a prescrição . [Internet] [Masters thesis]. Universidade do Rio Grande do Norte; 2012. [cited 2021 Feb 28]. Available from: http://repositorio.ufrn.br/handle/123456789/13473.

Council of Science Editors:

Dantas TAC. A propaganda de medicamentos voltados à clínica obstétrica e/ou ginecológica e sua influência sobre a prescrição . [Masters Thesis]. Universidade do Rio Grande do Norte; 2012. Available from: http://repositorio.ufrn.br/handle/123456789/13473

Queens University

8. Pulver, Ariel. Recreational use of prescription medications among Canadian young people: Identifying demographic and geographic disparities .

Degree: Community Health and Epidemiology, 2013, Queens University

URL: http://hdl.handle.net/1974/8369

► BACKGROUND: The nonmedical use of prescription medications among young people has escalated substantially in recent years. Certain subgroups of adolescents are at greater risk than… (more)

▼ BACKGROUND: The nonmedical use of prescription medications among young people has escalated substantially in recent years. Certain subgroups of adolescents are at greater risk than others, including rural youth, however this has yet to be adequately quantified in Canada, and risk and protective factors in rural communities remain understudied. OBJECTIVES: The first objective of this thesis was to characterize the nonmedical use of prescription drugs in Canadian youth by age, gender, socioeconomic, immigrant and geographic statuses. The second objective was to examine time-use patterns among rural young people as they may relate to their risk of using prescription drugs recreationally. METHODS: Data were obtained from 10,429 youth in grades 9 and 10 across Canada who participated in the 2009/2010 Cycle of the Health Behaviour in School-aged Children survey. Participants documented information about their nonmedical use of opioid pain relievers, stimulants and sedative or tranquilizer medications in the past year. Cross-tabulations and multi-level regression analyses were used to determine proportions and estimate risk by demographic subgroups, and among 2393 rural youth, to examine associations with time-use patterns RESULTS: Females were 1.25 times more likely to report recreational use of pain relievers (95% CI: 1.04-1.51). Lower SES students were 2.41 times more likely to report recreational use of any type of medication (95% CI: 1.94-2.99). Pain reliever use was highest among rural youth living in close proximity to urban centres. Frequent peer time after school and in the evenings was associated with a 1.73 (95% CI: 1.10-2.73) and 2.16 times (95% CI: 1.30-3.60) increased risk of using prescription drugs recreationally, however associations were attenuated when adjusted for other risk factors. Non-participation in extracurricular activities was associated with a 50% increase in risk for nonmedical use of prescription drugs, even when adjusted for other risk factors. CONCLUSIONS: Females, those of low SES and some rural youth, especially those who do not participate in extracurricular activities, are at increased risk for using prescription drugs recreationally. Results from this thesis point to priority areas for public health and education in reducing harms associated with nonmedical use of prescription drugs.

Subjects/Keywords: Epidemiology ; Prescription drug abuse ; Adolescent ; Substance abuse

Record Details Similar Records Cite « Share

❌

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6^th Edition):

Pulver, A. (2013). Recreational use of prescription medications among Canadian young people: Identifying demographic and geographic disparities . (Thesis). Queens University. Retrieved from http://hdl.handle.net/1974/8369

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16^th Edition):

Pulver, Ariel. “Recreational use of prescription medications among Canadian young people: Identifying demographic and geographic disparities .” 2013. Thesis, Queens University. Accessed February 28, 2021. http://hdl.handle.net/1974/8369.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7^th Edition):

Pulver, Ariel. “Recreational use of prescription medications among Canadian young people: Identifying demographic and geographic disparities .” 2013. Web. 28 Feb 2021.

Vancouver:

Pulver A. Recreational use of prescription medications among Canadian young people: Identifying demographic and geographic disparities . [Internet] [Thesis]. Queens University; 2013. [cited 2021 Feb 28]. Available from: http://hdl.handle.net/1974/8369.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Pulver A. Recreational use of prescription medications among Canadian young people: Identifying demographic and geographic disparities . [Thesis]. Queens University; 2013. Available from: http://hdl.handle.net/1974/8369

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

University of Sydney

9. Blanch, Bianca. What is normal? A critical analysis of the methods quantifying prescription drug use and potential misuse in pharmaceutical claims .

Degree: 2016, University of Sydney

URL: http://hdl.handle.net/2123/16910

► Our overall objective is to examine methods of quantifying prescription drug misuse in pharmaceutical claims. We approach this by undertaking a systematic review of the… (more)

▼ Our overall objective is to examine methods of quantifying prescription drug misuse in pharmaceutical claims. We approach this by undertaking a systematic review of the global literature measuring the extent of prescription drug misuse in pharmaceutical claims. Our review highlights four measures, number of prescribers, number of dispensing pharmacies, volume of drug dispensed and number of early refills, are used frequently to define prescription drug misuse. Despite this homogeneity, we found heterogeneity in the thresholds delineating use from misuse and a lack of established or validated benchmarks to accurately measure misuse in pharmaceutical claims. In our empirical work, we focus on prescription opioid analgesics due to the recent and considerable global increase in use and opioid- related harms. We use publically available, routinely collected data to document increases in prescription opioid use and related harms in Australia over 20 years. Over three chapters we explore population norms of prescription drug access in national dispensing claims and examine how access patterns relate to the metrics defining ‘misuse’ identified in our systematic review. We compare prescription drug access in Australia and British Columbia, Canada, for prescription opioids and statins, drug classes with high or no known abuse potential, respectively. We found access norms are remarkably similar across drug classes and healthcare settings. However, extreme access patterns are more common in people dispensed opioids, younger age groups or those receiving income assistance. We then examine opioid access in Australian adults initiating or reinitiating strong opioid treatment. We found the standard metrics defining ‘misuse’, including doctor and pharmacy shopping, are non-specific in that they identify misuse, but are also likely to capture high-need patient groups including individuals with a history of cancer treatment. From a translational perspective, our findings are particularly important as the US Food and Drug Administration recently endorsed using routinely collected data, including pharmaceutical claims, to quantify prescription opioid misuse and measure the effectiveness of interventions aimed to curb the ‘opioid epidemic’. We recommend using these commonly established metrics with caution due to their inability to isolate a population of people misusing opioids.

Subjects/Keywords: Prescription drug; opioidanalgesic; epidemiology; pharmaceutical benefits scheme

Record Details Similar Records Cite « Share

❌

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6^th Edition):

Blanch, B. (2016). What is normal? A critical analysis of the methods quantifying prescription drug use and potential misuse in pharmaceutical claims . (Thesis). University of Sydney. Retrieved from http://hdl.handle.net/2123/16910

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16^th Edition):

Blanch, Bianca. “What is normal? A critical analysis of the methods quantifying prescription drug use and potential misuse in pharmaceutical claims .” 2016. Thesis, University of Sydney. Accessed February 28, 2021. http://hdl.handle.net/2123/16910.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7^th Edition):

Blanch, Bianca. “What is normal? A critical analysis of the methods quantifying prescription drug use and potential misuse in pharmaceutical claims .” 2016. Web. 28 Feb 2021.

Vancouver:

Blanch B. What is normal? A critical analysis of the methods quantifying prescription drug use and potential misuse in pharmaceutical claims . [Internet] [Thesis]. University of Sydney; 2016. [cited 2021 Feb 28]. Available from: http://hdl.handle.net/2123/16910.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Blanch B. What is normal? A critical analysis of the methods quantifying prescription drug use and potential misuse in pharmaceutical claims . [Thesis]. University of Sydney; 2016. Available from: http://hdl.handle.net/2123/16910

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Xavier University

10. Gallagher, Lisa A. College Students' Perceptions of Prescription and Non-Prescription Drug Use.

Degree: Doctor of Psychology (Psy.D.), Psychology, 2018, Xavier University

URL: http://rave.ohiolink.edu/etdc/view?acc_num=xavier152811430792606

► Nonmedical use of prescription stimulants is increasingly common among college students (Schulenberg, Johnston, O’Malley, Bachman, Miech, & Patrick, 2017). Research into the motives behind this… (more)

Subjects/Keywords: Psychology; Prescription drug use, stimulants, Adderall, NMPDM, non-prescription drug use, diverted prescription use, college students, non medical prescription drug misuse, perceptions of drug use, substance misuse

Record Details Similar Records Cite « Share

❌

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6^th Edition):

Gallagher, L. A. (2018). College Students' Perceptions of Prescription and Non-Prescription Drug Use. (Doctoral Dissertation). Xavier University. Retrieved from http://rave.ohiolink.edu/etdc/view?acc_num=xavier152811430792606

Chicago Manual of Style (16^th Edition):

Gallagher, Lisa A. “College Students' Perceptions of Prescription and Non-Prescription Drug Use.” 2018. Doctoral Dissertation, Xavier University. Accessed February 28, 2021. http://rave.ohiolink.edu/etdc/view?acc_num=xavier152811430792606.

MLA Handbook (7^th Edition):

Gallagher, Lisa A. “College Students' Perceptions of Prescription and Non-Prescription Drug Use.” 2018. Web. 28 Feb 2021.

Vancouver:

Gallagher LA. College Students' Perceptions of Prescription and Non-Prescription Drug Use. [Internet] [Doctoral dissertation]. Xavier University; 2018. [cited 2021 Feb 28]. Available from: http://rave.ohiolink.edu/etdc/view?acc_num=xavier152811430792606.

Council of Science Editors:

Gallagher LA. College Students' Perceptions of Prescription and Non-Prescription Drug Use. [Doctoral Dissertation]. Xavier University; 2018. Available from: http://rave.ohiolink.edu/etdc/view?acc_num=xavier152811430792606

Drexel University

11. Ekejiuba, Kelechi. A Strategic Approach to Decreasing Prescription Drug Abuse amongst College Students.

Degree: 2012, Drexel University

URL: http://hdl.handle.net/1860/4020

►

Objectives: To assess the attitudes and culture of prescription drug misuse amongst undergraduate students. To assess students knowledge of, their perceived risks, and severity of… (more)

▼

Objectives: To assess the attitudes and culture of prescription drug misuse amongst undergraduate students. To assess students knowledge of, their perceived risks, and severity of misusing prescription drugs, and the accessibility of prescription drugs on campus. To examine the relationship between academic status and prescription drug misuse. To develop a Public Service Announcement to create awareness on this issue, and propose appropriate prevention programs using the Ecological Model of behavioral change. Methods: This is a cross-sectional study involving 50 undergraduate Drexel University students, ages 18 and older. Students were recruited from the Main Campus to complete an anonymous 35-question survey to assess their perceptions, beliefs, and attitudes towards prescription drug misuse. Results: 22% of students in this study reported misusing prescription drugs in their lifetime, while 44% of students reported abusing illicit drugs in their lifetime. Older students 24 years old and above are more likely to misuse prescription drugs than younger students. Most students reported stimulants (58%) and painkillers (52%) to be the most accessible prescription drugs on campus. 90% of students reported marijuana as the most accessible illegal drug. 70% of students feel that they could gain access to prescription drugs by asking other students on campus, with 40% of students claiming to know at least one student to ask for prescription drugs. In this study, academic status was not significantly correlated with prescription drug misuse; however, students with lower grade point average appeared to misuse prescription drugs more than students with higher grade point average. Perceived risks and severity of prescription drug misuse varied; however, majority of students reported some risks associated with prescription drug and illegal drug abuse. Conclusions: Lifetime misuse of prescription and illicit drugs is somewhat common amongst Drexel University undergraduate students surveyed at the Main Campus. This study found that students risk perceptions about drug misuse and their perceived ease of access to drugs could influence their choice to abuse prescription and illicit drugs. It was difficult proving statistical significance for some correlations due to the sample size of this study. Hence, a larger sample study on this topic is recommended in order to be able to generalize the findings to the rest of the Drexel University students. A PSA is being done to create awareness on this issue, and correct students misunderstanding of the effects of drug misuse and prevention programs should be put in place through the C.H.O.I.C.E.S Center at Drexel University.

M.P.H., Public Health – Drexel University, 2012

Advisors/Committee Members: Lankenau, Stephen.

Subjects/Keywords: Public Health; College Students; Prescription Drug Abuse

Record Details Similar Records Cite « Share

❌

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6^th Edition):

Ekejiuba, K. (2012). A Strategic Approach to Decreasing Prescription Drug Abuse amongst College Students. (Thesis). Drexel University. Retrieved from http://hdl.handle.net/1860/4020

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16^th Edition):

Ekejiuba, Kelechi. “A Strategic Approach to Decreasing Prescription Drug Abuse amongst College Students.” 2012. Thesis, Drexel University. Accessed February 28, 2021. http://hdl.handle.net/1860/4020.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7^th Edition):

Ekejiuba, Kelechi. “A Strategic Approach to Decreasing Prescription Drug Abuse amongst College Students.” 2012. Web. 28 Feb 2021.

Vancouver:

Ekejiuba K. A Strategic Approach to Decreasing Prescription Drug Abuse amongst College Students. [Internet] [Thesis]. Drexel University; 2012. [cited 2021 Feb 28]. Available from: http://hdl.handle.net/1860/4020.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Ekejiuba K. A Strategic Approach to Decreasing Prescription Drug Abuse amongst College Students. [Thesis]. Drexel University; 2012. Available from: http://hdl.handle.net/1860/4020

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

University of New South Wales

12. Hulme, Shann. The diversion and supply of pharmaceutical drugs for non-medical use.

Degree: Public Health & Community Medicine, 2019, University of New South Wales

URL: http://handle.unsw.edu.au/1959.4/64889 ; https://unsworks.unsw.edu.au/fapi/datastream/unsworks:62847/SOURCE02?view=true

► Consistent with international trends, in 2016 Australia experienced its highest number of drug-related deaths in 20 years, with most attributed to pharmaceutical opioids and benzodiazepines.… (more)

▼ Consistent with international trends, in 2016 Australia experienced its highest number of drug-related deaths in 20 years, with most attributed to pharmaceutical opioids and benzodiazepines. A large international evidence-base exists on mechanisms, drivers and profitability of illicit drug supply, yet equivalent research examining pharmaceutical drugs is scarce. This thesis aimed to fill this gap by examining, through four empirical studies, the diversion and supply of pharmaceutical drugs for non-medical use.First, a systematic review and meta-analysis pooled results from 34 international studies to estimate the prevalence of medical and non-medical/intermediary sourcing and diversion. Most pharmaceuticals for non-medical use were sourced via friends/family (57%, 95% CI 53%-62%) and few studies examined supply beyond end-user perspectives. Addressing this gap, the role of health practitioners and suppliers in Australia was explored next. Diversion from the medical system was examined through 117 cases of health practitioner misconduct using AustLII records. Persistent over-prescribing by a small number of practitioners due to inadequate skills to manage complex patient groups was identified. The final two empirical chapters analysed data from semi-structured interviews with 51 people involved in supplying pharmaceutical drugs. Negative binomial regressions and thematic analysis explored drug sourcing and motivations. Suppliers used medical (47% legitimate, 7% illegitimate prescriptions) and intermediary sources (e.g. 18% friends/family) and were financially (65%) and/or altruistically (61%) motivated. Those using illegitimate medical sources distributed larger quantities, while altruistically motivated suppliers distributed smaller quantities (e.g. leftover supplies) to people with perceived therapeutic need. Mark-up calculations showed that for every dollar-invested, suppliers earned 3.19 (median) or 19.90 (mean). Mixed-effects regressions found mark-up was predicted by source, such that mark-up was higher for medically sourced drugs, compared with those sourced via intermediaries (median 13.49 cf. 1.23).This research holds implications for research, policy and practice. The supply chain for pharmaceutical diversion is shorter than for illicit drugs and supply mechanisms and motives are diverse, warranting multifaceted responses. For example: 1) prescription monitoring for the small number of high-volume suppliers, 2) broader education for social supply, 3) consideration of supplier motive at sentencing, 4) support for health practitioners, and 5) addressing demand factors in marginalised populations. Advisors/Committee Members: Nielsen, Suzanne, Monash University, Hughes, Caitlin, Flinders University.

Subjects/Keywords: Drug supply; Pharmaceutical diversion; Prescription drug misuse; Black market; Drug dealing

Record Details Similar Records Cite « Share

❌

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6^th Edition):

Hulme, S. (2019). The diversion and supply of pharmaceutical drugs for non-medical use. (Doctoral Dissertation). University of New South Wales. Retrieved from http://handle.unsw.edu.au/1959.4/64889 ; https://unsworks.unsw.edu.au/fapi/datastream/unsworks:62847/SOURCE02?view=true

Chicago Manual of Style (16^th Edition):

Hulme, Shann. “The diversion and supply of pharmaceutical drugs for non-medical use.” 2019. Doctoral Dissertation, University of New South Wales. Accessed February 28, 2021. http://handle.unsw.edu.au/1959.4/64889 ; https://unsworks.unsw.edu.au/fapi/datastream/unsworks:62847/SOURCE02?view=true.

MLA Handbook (7^th Edition):

Hulme, Shann. “The diversion and supply of pharmaceutical drugs for non-medical use.” 2019. Web. 28 Feb 2021.

Vancouver:

Hulme S. The diversion and supply of pharmaceutical drugs for non-medical use. [Internet] [Doctoral dissertation]. University of New South Wales; 2019. [cited 2021 Feb 28]. Available from: http://handle.unsw.edu.au/1959.4/64889 ; https://unsworks.unsw.edu.au/fapi/datastream/unsworks:62847/SOURCE02?view=true.

Council of Science Editors:

Hulme S. The diversion and supply of pharmaceutical drugs for non-medical use. [Doctoral Dissertation]. University of New South Wales; 2019. Available from: http://handle.unsw.edu.au/1959.4/64889 ; https://unsworks.unsw.edu.au/fapi/datastream/unsworks:62847/SOURCE02?view=true

University of Louisville

13. Friley, Lorin Brooke. Teenage pharmapocalypse? : an exploratory examination of prescription drug abuse.

Degree: MA, 2011, University of Louisville

URL: 10.18297/etd/461 ; https://ir.library.louisville.edu/etd/461

► The purpose of this study was to examine the phenomenon of teenage prescription drug abuse in Jefferson County, Kentucky to gain a better understanding of… (more)

Subjects/Keywords: Teenage prescription drug abuse; Adolescent prescription drug abuse; Adolescent drug abuse; Adolescent substance abuse; Teenage substance use; Adolescent substance use

Record Details Similar Records Cite « Share

❌

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6^th Edition):

Friley, L. B. (2011). Teenage pharmapocalypse? : an exploratory examination of prescription drug abuse. (Masters Thesis). University of Louisville. Retrieved from 10.18297/etd/461 ; https://ir.library.louisville.edu/etd/461

Chicago Manual of Style (16^th Edition):

Friley, Lorin Brooke. “Teenage pharmapocalypse? : an exploratory examination of prescription drug abuse.” 2011. Masters Thesis, University of Louisville. Accessed February 28, 2021. 10.18297/etd/461 ; https://ir.library.louisville.edu/etd/461.

MLA Handbook (7^th Edition):

Friley, Lorin Brooke. “Teenage pharmapocalypse? : an exploratory examination of prescription drug abuse.” 2011. Web. 28 Feb 2021.

Vancouver:

Friley LB. Teenage pharmapocalypse? : an exploratory examination of prescription drug abuse. [Internet] [Masters thesis]. University of Louisville; 2011. [cited 2021 Feb 28]. Available from: 10.18297/etd/461 ; https://ir.library.louisville.edu/etd/461.

Council of Science Editors:

Friley LB. Teenage pharmapocalypse? : an exploratory examination of prescription drug abuse. [Masters Thesis]. University of Louisville; 2011. Available from: 10.18297/etd/461 ; https://ir.library.louisville.edu/etd/461

University of Toronto

14. Zhang, Yang Maria. Novel Approaches in Assessing Abuse Potential of Psychotropic Medications – Pregabalin as a Test Case.

Degree: 2016, University of Toronto

URL: http://hdl.handle.net/1807/71706

►

Abuse of psychotropic medications causes significant morbidity and mortality in North America. Results from traditional assessments of abuse liability may not be generalizable to individuals… (more)

Subjects/Keywords: addiction; database; drug abuse; pregabalin; prescription drug abuse; psychotropic; 0572

Record Details Similar Records Cite « Share

❌

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6^th Edition):

Zhang, Y. M. (2016). Novel Approaches in Assessing Abuse Potential of Psychotropic Medications – Pregabalin as a Test Case. (Masters Thesis). University of Toronto. Retrieved from http://hdl.handle.net/1807/71706

Chicago Manual of Style (16^th Edition):

Zhang, Yang Maria. “Novel Approaches in Assessing Abuse Potential of Psychotropic Medications – Pregabalin as a Test Case.” 2016. Masters Thesis, University of Toronto. Accessed February 28, 2021. http://hdl.handle.net/1807/71706.

MLA Handbook (7^th Edition):

Zhang, Yang Maria. “Novel Approaches in Assessing Abuse Potential of Psychotropic Medications – Pregabalin as a Test Case.” 2016. Web. 28 Feb 2021.

Vancouver:

Zhang YM. Novel Approaches in Assessing Abuse Potential of Psychotropic Medications – Pregabalin as a Test Case. [Internet] [Masters thesis]. University of Toronto; 2016. [cited 2021 Feb 28]. Available from: http://hdl.handle.net/1807/71706.

Council of Science Editors:

Zhang YM. Novel Approaches in Assessing Abuse Potential of Psychotropic Medications – Pregabalin as a Test Case. [Masters Thesis]. University of Toronto; 2016. Available from: http://hdl.handle.net/1807/71706

Georgia State University

15. Zesiger, Heather A, PhD. Opioid Misuse Among Students Pursuing Higher Education.

Degree: PhD, Public Health, 2018, Georgia State University

URL: https://scholarworks.gsu.edu/sph_diss/22

► Background: Despite national attention on opioid abuse, little is known about opioid misuse (OM; defined as heroin use or non-medical use of opioid prescription… (more)

▼ Background: Despite national attention on opioid abuse, little is known about opioid misuse (OM; defined as heroin use or non-medical use of opioid prescription drugs) among students pursuing higher education in the United States. A better understanding of student OM is necessary to inform a public health process to develop campus-specific prevention strategies and interventions. This dissertation examined three main questions: 1) what individual, social and institutional characteristics are associated with OM, 2) Is OM elevated among student service members/veterans, and 3) whether OM is associated with comorbidities including mental and physical diagnoses, sleep, and suicidality, as well as whether the effect of OM on suicidality is mediated by its effects on sleep quality? Methods: Data were from full-time students (N = 91,322) enrolled at 103 institutions that participated in the spring 2015 American College Health Association–National College Health Assessment survey. Multilevel modeling and binary logistic regression were used to examine associations between individual, social, and school-level predictors and OM. Results: The prevalence of opioid misuse was 7% (N = 6,376). OM was associated with several individual, social and institutional characteristics, such as being an undergraduate versus graduate student (OR = 1.26, 95% CI = [1.179, 1.348]). Analyses showed that being a student service member/veteran (SSM/V) who had served in hazardous duty increased the odds of OM by roughly 31% (OR = 1.309, 95% CI = 1.113, 1.539). Likewise, students who reported misusing opioids were twice as likely to report having suicidal ideation or a past suicide attempt (OR = 2.317, 95% CI = [2.193, 2.448]), and a number of other health outcomes, such as chronic illness, anxiety, and depression. Mediation analyses in MPlus showed that sleeping difficulties partially mediated the relationship between OM and suicidality. Conclusion: OM has devastating economic, social and medical consequences for individuals and communities. Significant associations between individual characteristics, comorbid conditions, and social environmental structures and OM among students in higher education highlight the need to illuminate other risk and protective factors as well as to identify effective clinical and environmental interventions to reduce harm and save lives on campus. Advisors/Committee Members: Sheryl Strasser, PhD, Ashli Owen-Smith, PhD, Michael Huey, MD.

Subjects/Keywords: drug use; students; prescription drug misuse; heroin; suicide; veterans

Record Details Similar Records Cite « Share

❌

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6^th Edition):

Zesiger, Heather A, P. (2018). Opioid Misuse Among Students Pursuing Higher Education. (Doctoral Dissertation). Georgia State University. Retrieved from https://scholarworks.gsu.edu/sph_diss/22

Chicago Manual of Style (16^th Edition):

Zesiger, Heather A, PhD. “Opioid Misuse Among Students Pursuing Higher Education.” 2018. Doctoral Dissertation, Georgia State University. Accessed February 28, 2021. https://scholarworks.gsu.edu/sph_diss/22.

MLA Handbook (7^th Edition):

Zesiger, Heather A, PhD. “Opioid Misuse Among Students Pursuing Higher Education.” 2018. Web. 28 Feb 2021.

Vancouver:

Zesiger, Heather A P. Opioid Misuse Among Students Pursuing Higher Education. [Internet] [Doctoral dissertation]. Georgia State University; 2018. [cited 2021 Feb 28]. Available from: https://scholarworks.gsu.edu/sph_diss/22.

Council of Science Editors:

Zesiger, Heather A P. Opioid Misuse Among Students Pursuing Higher Education. [Doctoral Dissertation]. Georgia State University; 2018. Available from: https://scholarworks.gsu.edu/sph_diss/22

Vanderbilt University

16. White, Steven John. Design and implementation of a computerized informatics tool to facilitate clinician access to a state’s prescription drug monitoring program database.

Degree: MS, Biomedical Informatics, 2013, Vanderbilt University

URL: http://hdl.handle.net/1803/10791

► BIOMEDICAL INFORMATICS DESIGN AND IMPLEMENTATION OF A COMPUTERIZED INFORMATICS TOOL TO FACILITATE CLINICIAN ACCESS TO A STATE’S PRESCRIPTION DRUG MONITORING PROGRAM DATABASE STEVEN JOHN WHITE… (more)

▼ BIOMEDICAL INFORMATICS DESIGN AND IMPLEMENTATION OF A COMPUTERIZED INFORMATICS TOOL TO FACILITATE CLINICIAN ACCESS TO A STATE’S PRESCRIPTION DRUG MONITORING PROGRAM DATABASE STEVEN JOHN WHITE Thesis under the direction of Professor Dario Giuse Within the past decade, prescription drug abuse has emerged as a nationwide epidemic, with opioid-related poisoning deaths more than tripling since 1999. In an effort to bring this public health crisis under control, 43 states, including Tennessee, have enacted prescription drug monitoring programs (PDMPs), computerized databases of DEA-controlled substance prescriptions filled at pharmacies within the given state. Such programs have been found to be effective in curbing prescription opioid abuse by alerting prescribers to aberrant prescription-filling activity. However, they are commonly underutilized and have workflow barriers that impede clinical use. Ideally, PDMP queries could be generated seamlessly from within a medical enterprise’s electronic health record (EHR) system, using an application-programming interface (API) supplied by the state’s PDMP vendor. However, the enabling legislative language currently prohibits such access. Therefore, we developed and evaluated a Perl software program activated from within Vanderbilt University Medical Center’s EHR patient chart to send the properly coded/formatted user and patient-demographic information packets to the Tennessee PDMP website, without the use of an API. The program parses the returned data file for important prescription information and displays the filtered information to the user. By allowing the query to occur in the background, the user’s tether time to the computer is decreased from 3 minutes to 10 seconds per query. During the evaluation phase, we used a quasi-experimental intervention design with two alternating 2-week control and intervention periods. Twenty-eight ED attending physicians participated in the study and queried the PDMP at their clinical discretion. During integrated PDMP query tool availability, 5.9 % (169/2844) of emergency department patients were screened compared with 2.2 % (62/2786) during periods when the tool was not available (p<0.001, Pearson’s Chi square). Data was not viewed in 20% of integrated tool assisted queries. The EHR-integrated PDMP query tool was well regarded by study physicians as an enhancement to workflow. Advisors/Committee Members: Dominik Aronsky (committee member), Ian Jones (committee member), Dario Giuse (Committee Chair).

Subjects/Keywords: controlled substances monitoring database; opioid prescriptions; opioid abuse; prescription misuse; prescription abuse; drug-seeking; prescription monitoring program; PMP; CSMD

Record Details Similar Records Cite « Share

❌

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6^th Edition):

White, S. J. (2013). Design and implementation of a computerized informatics tool to facilitate clinician access to a state’s prescription drug monitoring program database. (Thesis). Vanderbilt University. Retrieved from http://hdl.handle.net/1803/10791

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16^th Edition):

White, Steven John. “Design and implementation of a computerized informatics tool to facilitate clinician access to a state’s prescription drug monitoring program database.” 2013. Thesis, Vanderbilt University. Accessed February 28, 2021. http://hdl.handle.net/1803/10791.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7^th Edition):

White, Steven John. “Design and implementation of a computerized informatics tool to facilitate clinician access to a state’s prescription drug monitoring program database.” 2013. Web. 28 Feb 2021.

Vancouver:

White SJ. Design and implementation of a computerized informatics tool to facilitate clinician access to a state’s prescription drug monitoring program database. [Internet] [Thesis]. Vanderbilt University; 2013. [cited 2021 Feb 28]. Available from: http://hdl.handle.net/1803/10791.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

White SJ. Design and implementation of a computerized informatics tool to facilitate clinician access to a state’s prescription drug monitoring program database. [Thesis]. Vanderbilt University; 2013. Available from: http://hdl.handle.net/1803/10791

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

University of Florida

17. Delcher, Philip Chris. MONITORING OPIOID ABUSE AND DOCTOR SHOPPING AN EPIDEMIOLOGIC PERSPECTIVE IN PERSON, PLACE, AND TIME.

Degree: PhD, Epidemiology, 2014, University of Florida

URL: https://ufdc.ufl.edu/UFE0046666

► Prescription drug abuse is a national epidemic in the United States. Prescription pain relievers, in particular, are highly abused despite regulatory oversight to control their… (more)

Subjects/Keywords: Death; Drug prescriptions; Health care industry; Medicaid; Mortality; Opioid analgesics; Pain; Predisposing factors; Prescription drugs; Shopping; abuse – drug – prescription

Record Details Similar Records Cite « Share

❌

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6^th Edition):

Delcher, P. C. (2014). MONITORING OPIOID ABUSE AND DOCTOR SHOPPING AN EPIDEMIOLOGIC PERSPECTIVE IN PERSON, PLACE, AND TIME. (Doctoral Dissertation). University of Florida. Retrieved from https://ufdc.ufl.edu/UFE0046666

Chicago Manual of Style (16^th Edition):

Delcher, Philip Chris. “MONITORING OPIOID ABUSE AND DOCTOR SHOPPING AN EPIDEMIOLOGIC PERSPECTIVE IN PERSON, PLACE, AND TIME.” 2014. Doctoral Dissertation, University of Florida. Accessed February 28, 2021. https://ufdc.ufl.edu/UFE0046666.

MLA Handbook (7^th Edition):

Delcher, Philip Chris. “MONITORING OPIOID ABUSE AND DOCTOR SHOPPING AN EPIDEMIOLOGIC PERSPECTIVE IN PERSON, PLACE, AND TIME.” 2014. Web. 28 Feb 2021.

Vancouver:

Delcher PC. MONITORING OPIOID ABUSE AND DOCTOR SHOPPING AN EPIDEMIOLOGIC PERSPECTIVE IN PERSON, PLACE, AND TIME. [Internet] [Doctoral dissertation]. University of Florida; 2014. [cited 2021 Feb 28]. Available from: https://ufdc.ufl.edu/UFE0046666.

Council of Science Editors:

Delcher PC. MONITORING OPIOID ABUSE AND DOCTOR SHOPPING AN EPIDEMIOLOGIC PERSPECTIVE IN PERSON, PLACE, AND TIME. [Doctoral Dissertation]. University of Florida; 2014. Available from: https://ufdc.ufl.edu/UFE0046666

Mississippi State University

18. Kinman, Brittany A. Using the Health Belief Model to identify factors that prevent non-prescription stimulant use.

Degree: PhD, Psychology, 2018, Mississippi State University

URL: http://sun.library.msstate.edu/ETD-db/theses/available/etd-06282018-114641/ ;

► The present study used the Health Belief Model (HBM) to better understand how perceived susceptibility and severity (perceived threat) can contribute to college students… (more)

Subjects/Keywords: drug use; stimulant use; non-prescription stimulant use; college students

Record Details Similar Records Cite « Share

❌

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6^th Edition):

Kinman, B. A. (2018). Using the Health Belief Model to identify factors that prevent non-prescription stimulant use. (Doctoral Dissertation). Mississippi State University. Retrieved from http://sun.library.msstate.edu/ETD-db/theses/available/etd-06282018-114641/ ;

Chicago Manual of Style (16^th Edition):

Kinman, Brittany A. “Using the Health Belief Model to identify factors that prevent non-prescription stimulant use.” 2018. Doctoral Dissertation, Mississippi State University. Accessed February 28, 2021. http://sun.library.msstate.edu/ETD-db/theses/available/etd-06282018-114641/ ;.

MLA Handbook (7^th Edition):

Kinman, Brittany A. “Using the Health Belief Model to identify factors that prevent non-prescription stimulant use.” 2018. Web. 28 Feb 2021.

Vancouver:

Kinman BA. Using the Health Belief Model to identify factors that prevent non-prescription stimulant use. [Internet] [Doctoral dissertation]. Mississippi State University; 2018. [cited 2021 Feb 28]. Available from: http://sun.library.msstate.edu/ETD-db/theses/available/etd-06282018-114641/ ;.

Council of Science Editors:

Kinman BA. Using the Health Belief Model to identify factors that prevent non-prescription stimulant use. [Doctoral Dissertation]. Mississippi State University; 2018. Available from: http://sun.library.msstate.edu/ETD-db/theses/available/etd-06282018-114641/ ;

University of Utah

19. Kitchens, Connie L. Identification of behavioral risk factors for medically unsupervised use of prescription medications in Utah.

Degree: PhD, Family & Preventive Medicine;, 2010, University of Utah

URL: http://content.lib.utah.edu/cdm/singleitem/collection/etd2/id/1359/rec/603

► Prescription drug misuse has become a widespread problem in the United States. Misuse of prescription drugs is second only to marijuana as the nation’s most… (more)

Subjects/Keywords: Nonmedical prescription drug use; Risk factors; Medication abuse

Record Details Similar Records Cite « Share

❌

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6^th Edition):

Kitchens, C. L. (2010). Identification of behavioral risk factors for medically unsupervised use of prescription medications in Utah. (Doctoral Dissertation). University of Utah. Retrieved from http://content.lib.utah.edu/cdm/singleitem/collection/etd2/id/1359/rec/603

Chicago Manual of Style (16^th Edition):

Kitchens, Connie L. “Identification of behavioral risk factors for medically unsupervised use of prescription medications in Utah.” 2010. Doctoral Dissertation, University of Utah. Accessed February 28, 2021. http://content.lib.utah.edu/cdm/singleitem/collection/etd2/id/1359/rec/603.

MLA Handbook (7^th Edition):

Kitchens, Connie L. “Identification of behavioral risk factors for medically unsupervised use of prescription medications in Utah.” 2010. Web. 28 Feb 2021.

Vancouver:

Kitchens CL. Identification of behavioral risk factors for medically unsupervised use of prescription medications in Utah. [Internet] [Doctoral dissertation]. University of Utah; 2010. [cited 2021 Feb 28]. Available from: http://content.lib.utah.edu/cdm/singleitem/collection/etd2/id/1359/rec/603.

Council of Science Editors:

Kitchens CL. Identification of behavioral risk factors for medically unsupervised use of prescription medications in Utah. [Doctoral Dissertation]. University of Utah; 2010. Available from: http://content.lib.utah.edu/cdm/singleitem/collection/etd2/id/1359/rec/603

Temple University

20. Neelakantan, Harshini. REWARD-RELATED BEHAVIORAL EFFECTS OF PRESCRIPTION OPIOIDS AS A FUNCTION OF PUTATIVE ACUTE AND CHRONIC PAIN-LIKE STATES IN MALE AND FEMALE C57BL/6 MICE.

Degree: PhD, 2014, Temple University

URL: http://digital.library.temple.edu/u?/p245801coll10,270439

►

Pharmaceutical Sciences

Pain is a leading cause of disability and the most common reason for clinical care. The field of pain research has focused on… (more)

▼

Pharmaceutical Sciences

Pain is a leading cause of disability and the most common reason for clinical care. The field of pain research has focused on sex differences in the recent years with an expansive body of literature demonstrating sex-related differences in pain behavior and responsiveness to pharmacological interventions. Prescription opioids are potent analgesics and the mainstay for the clinical management of moderate-to-severe acute and chronic pain conditions. However, the long-term clinical use of prescription opioids for chronic pain remains controversial due to concerns about severe adverse effects, including tolerance, dependence, and addiction associated with opioid use. The non-medical use and abuse of prescription opioids has become a public health crisis, the problem even arising in a subset of chronic pain patients receiving opioid therapy. The vulnerability factors, specifically the role of pain in the propensity to prescription opioid abuse, are poorly understood. The present research project sought to investigate the propensity to opioid reward as a function of pain in male and female mice by incorporating acute (acetic acid-induced) visceral nociceptive and chronic chemotherapy (paclitaxel)-induced peripheral neuropathic pain models. Sexually dimorphic variations in the sensitivities of mice to nociceptive and allodynic behaviors were initially assessed using the two putative pain models. Following that, the two prescription opioids, morphine and oxycodone were examined under both pain contexts and the capacity of the two prescription opioids to produce reward-related behavioral effects were measured using drug discrimination, conditioned place preference, and intravenous drug self-administration procedures. The presence of acute noxious state but not chronic pain selectively attenuated the discriminative stimulus effects of the prescription opioid, morphine in male mice. The magnitude of modulation of the stimulus effects of opioids by the acute noxious state were further observed to be inversely related to the relative intrinsic antinociceptive effectiveness of the two opioids in reversing the acute noxious state and sex-specific sensitivities of mice to opioid-induced antinociception. In contrast, while no change was observed in opioid-reward as a function of the acute noxious state in both sexes, the presence of paclitaxel-induced chronic pain opioid-selectively and dose-selectively enhanced the conditioned rewarding effect of morphine (0.3 mg/kg dose), and the effect was more pronounced in male relative to female mice. These data were further supported by the self-administration results, in that the reinforcing efficacy (breakpoints under progressive ratio (PR) responding) and the incentive-motivational salience of morphine significantly increased in the presence of chronic pain in male mice, while non-selectively increasing regardless of the presence/absence of pain in female mice. Overall, the converging empirical evidence presented here suggest that these models provide preclinical…

Advisors/Committee Members: Walker, Ellen A.;, Raffa, Robert B., Rawls, Scott M., Canney, Daniel J., Comer, Sandra D.;.

Subjects/Keywords: Pharmacology;

Record Details Similar Records Cite « Share

❌

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6^th Edition):

Neelakantan, H. (2014). REWARD-RELATED BEHAVIORAL EFFECTS OF PRESCRIPTION OPIOIDS AS A FUNCTION OF PUTATIVE ACUTE AND CHRONIC PAIN-LIKE STATES IN MALE AND FEMALE C57BL/6 MICE. (Doctoral Dissertation). Temple University. Retrieved from http://digital.library.temple.edu/u?/p245801coll10,270439

Chicago Manual of Style (16^th Edition):

Neelakantan, Harshini. “REWARD-RELATED BEHAVIORAL EFFECTS OF PRESCRIPTION OPIOIDS AS A FUNCTION OF PUTATIVE ACUTE AND CHRONIC PAIN-LIKE STATES IN MALE AND FEMALE C57BL/6 MICE.” 2014. Doctoral Dissertation, Temple University. Accessed February 28, 2021. http://digital.library.temple.edu/u?/p245801coll10,270439.

MLA Handbook (7^th Edition):

Neelakantan, Harshini. “REWARD-RELATED BEHAVIORAL EFFECTS OF PRESCRIPTION OPIOIDS AS A FUNCTION OF PUTATIVE ACUTE AND CHRONIC PAIN-LIKE STATES IN MALE AND FEMALE C57BL/6 MICE.” 2014. Web. 28 Feb 2021.

Vancouver:

Neelakantan H. REWARD-RELATED BEHAVIORAL EFFECTS OF PRESCRIPTION OPIOIDS AS A FUNCTION OF PUTATIVE ACUTE AND CHRONIC PAIN-LIKE STATES IN MALE AND FEMALE C57BL/6 MICE. [Internet] [Doctoral dissertation]. Temple University; 2014. [cited 2021 Feb 28]. Available from: http://digital.library.temple.edu/u?/p245801coll10,270439.

Council of Science Editors:

Neelakantan H. REWARD-RELATED BEHAVIORAL EFFECTS OF PRESCRIPTION OPIOIDS AS A FUNCTION OF PUTATIVE ACUTE AND CHRONIC PAIN-LIKE STATES IN MALE AND FEMALE C57BL/6 MICE. [Doctoral Dissertation]. Temple University; 2014. Available from: http://digital.library.temple.edu/u?/p245801coll10,270439

Vanderbilt University

21. Philip Gentry, Anne Elissa. Safety and Effectiveness: The FDA’s Approach to Risk in Prescription Medication.

Degree: PhD, Law and Economics, 2016, Vanderbilt University

URL: http://hdl.handle.net/1803/12003

► The Food and Drug Administration (FDA) regulates the risks associated with pharmaceutical products; however, some drug uses are not directly regulated, and appropriate usage is… (more)

Subjects/Keywords: health; prescription drug; ambiguity; off-label; behavioral; risk

Record Details Similar Records Cite « Share

❌

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6^th Edition):

Philip Gentry, A. E. (2016). Safety and Effectiveness: The FDA’s Approach to Risk in Prescription Medication. (Doctoral Dissertation). Vanderbilt University. Retrieved from http://hdl.handle.net/1803/12003

Chicago Manual of Style (16^th Edition):

Philip Gentry, Anne Elissa. “Safety and Effectiveness: The FDA’s Approach to Risk in Prescription Medication.” 2016. Doctoral Dissertation, Vanderbilt University. Accessed February 28, 2021. http://hdl.handle.net/1803/12003.

MLA Handbook (7^th Edition):

Philip Gentry, Anne Elissa. “Safety and Effectiveness: The FDA’s Approach to Risk in Prescription Medication.” 2016. Web. 28 Feb 2021.

Vancouver:

Philip Gentry AE. Safety and Effectiveness: The FDA’s Approach to Risk in Prescription Medication. [Internet] [Doctoral dissertation]. Vanderbilt University; 2016. [cited 2021 Feb 28]. Available from: http://hdl.handle.net/1803/12003.

Council of Science Editors:

Philip Gentry AE. Safety and Effectiveness: The FDA’s Approach to Risk in Prescription Medication. [Doctoral Dissertation]. Vanderbilt University; 2016. Available from: http://hdl.handle.net/1803/12003

Penn State University

22. Crowley, Daniel Max. Evaluating The Cost-effectivness Of Real-world Prevention: Approaches For Estimating The Efficieny Of Evidence-based Programming.

Degree: 2012, Penn State University

URL: https://submit-etda.libraries.psu.edu/catalog/15529

► Successful demonstrations of evidence-based preventative interventions (EBPIs) have led to a growing interest in prevention’s capacity to reduce major public health problems with greater efficiency.… (more)

▼ Successful demonstrations of evidence-based preventative interventions (EBPIs) have led to a growing interest in prevention’s capacity to reduce major public health problems with greater efficiency. In response—just as prevention scientists once distinguished between the efficacy and effectiveness of prevention programs—now researchers are considering the distinction between program effectiveness and efficiency (i.e., contextualizing impact in terms of cost). This inquiry into the benefits and costs of EBPIs presents an opportunity to demonstrate prevention’s impact as well as its greater value to society. To accurately evaluate the efficiency of prevention efforts, program cost-effectiveness must be gauged in real-world contexts. In turn, new methodological approaches are needed to account for potential confounders that may reduce researcher’s ability to draw causal inferences about program impact. For instance, selection bias is introduced when local communities adopt one program over another and when the decision to enroll in multiple programs is left up to participants. This work demonstrates an innovative approach for assessing the efficiency of evidence-based preventive interventions delivered in everyday settings. Using data from the PROSPER dissemination trial (over 12,000 youth; 28 Communities), this project applies propensity and marginal structural models to strengthen causal inference within cost-effectiveness analyses of community prevention efforts. Using these analytic techniques, I evaluated the effectiveness and cost-effectiveness of three school programs (Life Skills Training, All Stars and Project Alert) and a family program (SFP 10-14) to reduce prescription opioid misuse (e.g., Vicodin, OxyContin). Findings indicated that universal school-based EBPIs can on their own reduce prescription opioid misuse in a cost-effective manner and that the efficiency of a prevention effort employing such school programs can be enhanced by deploying an additional family-based program. This methodological approach provides an opportunity to increase the relevance of prevention impact analyses by allowing researchers to better contextualize program effectiveness in terms of program costs. Specifically, this method provides a more refined approach for understanding the impact of combining interventions and may expedite the development of more efficient prevention efforts. Further, analyses such as these can provide important information to not only researchers, but to multiple stakeholders who seek to translate prevention science into practice. Advisors/Committee Members: Mark T Greenberg, Dissertation Advisor/Co-Advisor, Mark T Greenberg, Committee Chair/Co-Chair, Damon Evan Jones, Committee Chair/Co-Chair, Linda Marie Collins, Committee Member, Edward A Smith, Committee Member, Donna Coffman, Committee Member, Daniel Francis Perkins, Special Member, Steven Howard Zarit, Special Member.

Subjects/Keywords: Prevention Science; Cost-Effectiveness; Prescription Drug Misuse; Efficiency Analyses

Record Details Similar Records Cite « Share

❌

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6^th Edition):

Crowley, D. M. (2012). Evaluating The Cost-effectivness Of Real-world Prevention: Approaches For Estimating The Efficieny Of Evidence-based Programming. (Thesis). Penn State University. Retrieved from https://submit-etda.libraries.psu.edu/catalog/15529

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16^th Edition):

Crowley, Daniel Max. “Evaluating The Cost-effectivness Of Real-world Prevention: Approaches For Estimating The Efficieny Of Evidence-based Programming.” 2012. Thesis, Penn State University. Accessed February 28, 2021. https://submit-etda.libraries.psu.edu/catalog/15529.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7^th Edition):

Crowley, Daniel Max. “Evaluating The Cost-effectivness Of Real-world Prevention: Approaches For Estimating The Efficieny Of Evidence-based Programming.” 2012. Web. 28 Feb 2021.

Vancouver:

Crowley DM. Evaluating The Cost-effectivness Of Real-world Prevention: Approaches For Estimating The Efficieny Of Evidence-based Programming. [Internet] [Thesis]. Penn State University; 2012. [cited 2021 Feb 28]. Available from: https://submit-etda.libraries.psu.edu/catalog/15529.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Crowley DM. Evaluating The Cost-effectivness Of Real-world Prevention: Approaches For Estimating The Efficieny Of Evidence-based Programming. [Thesis]. Penn State University; 2012. Available from: https://submit-etda.libraries.psu.edu/catalog/15529

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Washington State University

23. [No author]. Pills, Patches, and Syrups, Oh My: An Exploratory Study of College Men's and Women's Non-Medical Prescription Drug Use .

Degree: 2013, Washington State University

URL: http://hdl.handle.net/2376/4799

► National surveys on substance use indicate that the prevalence of non-medical prescription drug use is now greater than the prevalence of illicit drugs other than… (more)

Subjects/Keywords: Sociology; college students; drug use; gender; prescription drugs

Record Details Similar Records Cite « Share

❌

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6^th Edition):

author], [. (2013). Pills, Patches, and Syrups, Oh My: An Exploratory Study of College Men's and Women's Non-Medical Prescription Drug Use . (Thesis). Washington State University. Retrieved from http://hdl.handle.net/2376/4799

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16^th Edition):

author], [No. “Pills, Patches, and Syrups, Oh My: An Exploratory Study of College Men's and Women's Non-Medical Prescription Drug Use .” 2013. Thesis, Washington State University. Accessed February 28, 2021. http://hdl.handle.net/2376/4799.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7^th Edition):

author], [No. “Pills, Patches, and Syrups, Oh My: An Exploratory Study of College Men's and Women's Non-Medical Prescription Drug Use .” 2013. Web. 28 Feb 2021.

Vancouver:

author] [. Pills, Patches, and Syrups, Oh My: An Exploratory Study of College Men's and Women's Non-Medical Prescription Drug Use . [Internet] [Thesis]. Washington State University; 2013. [cited 2021 Feb 28]. Available from: http://hdl.handle.net/2376/4799.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

author] [. Pills, Patches, and Syrups, Oh My: An Exploratory Study of College Men's and Women's Non-Medical Prescription Drug Use . [Thesis]. Washington State University; 2013. Available from: http://hdl.handle.net/2376/4799

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

University of New Mexico

24. Callan, Danelle. Medicare Part D Coverage Gap: Who Falls In and What Beneficiaries Do to Avoid Entry.

Degree: Department of Economics, 2012, University of New Mexico

URL: http://hdl.handle.net/1928/20313

► In 2006, the implementation of Medicare Part D offered seniors the benefit of government subsidized prescription drug coverage. The baby boomer generation is expected to… (more)

Subjects/Keywords: Medicare Part D; Economics; Health Economics; Prescription drug coverage; Doughnut hole

Record Details Similar Records Cite « Share

❌

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6^th Edition):

Callan, D. (2012). Medicare Part D Coverage Gap: Who Falls In and What Beneficiaries Do to Avoid Entry. (Masters Thesis). University of New Mexico. Retrieved from http://hdl.handle.net/1928/20313

Chicago Manual of Style (16^th Edition):

Callan, Danelle. “Medicare Part D Coverage Gap: Who Falls In and What Beneficiaries Do to Avoid Entry.” 2012. Masters Thesis, University of New Mexico. Accessed February 28, 2021. http://hdl.handle.net/1928/20313.

MLA Handbook (7^th Edition):

Callan, Danelle. “Medicare Part D Coverage Gap: Who Falls In and What Beneficiaries Do to Avoid Entry.” 2012. Web. 28 Feb 2021.

Vancouver:

Callan D. Medicare Part D Coverage Gap: Who Falls In and What Beneficiaries Do to Avoid Entry. [Internet] [Masters thesis]. University of New Mexico; 2012. [cited 2021 Feb 28]. Available from: http://hdl.handle.net/1928/20313.

Council of Science Editors:

Callan D. Medicare Part D Coverage Gap: Who Falls In and What Beneficiaries Do to Avoid Entry. [Masters Thesis]. University of New Mexico; 2012. Available from: http://hdl.handle.net/1928/20313

University of Minnesota

25. Kim, Jee-Ae. Medication Utilization of Dual Eligibles Before and After Medicare Part D: Cases of Antidepressants and Antipsychotics.

Degree: PhD, Health Services Research, Policy and Administration, 2014, University of Minnesota

URL: http://hdl.handle.net/11299/182292

► Objectives: The study objective is to examine whether medication utilization among dual eligibles was different under Part D compared to Medicaid period by focusing on… (more)

▼ Objectives: The study objective is to examine whether medication utilization among dual eligibles was different under Part D compared to Medicaid period by focusing on states which vary baseline state Medicaid policies and wrap-around programs for dual eligibles to access drugs under Part D. The transition of prescription drug benefits to federal Medicare Part D from state Medicaid has potential to affect medication utilization for dual eligibles, beneficiaries for both Medicaid and Medicare programs. Changes in prescription drug benefits under Part D will not equally affect the dual eligible and will differ by states with differences in baseline Medicaid policies and availability of wrap-around programs to access drugs under Part D. The study focuses on antidepressants and antipsychotics. Methods: This study is a pre-post study design with a longitudinal dataset by linking Medicaid data for 2004-2005 and 5% random sample of Medicare data for 2006-2007. The study population is dual eligibles, existing users of antidepressants and of antipsychotics in 2004 and with enrollment from 2004-2007 in eight states. I employ a state-fixed effect model to estimate medication utilization using proportion of days covered (PDC), adjusting for beneficiaries characteristics and health status. I adopt generalized estimation equation (GEE) model for estimating PDC and spline regression for investigating whether changes in PDCs were related to Part D. A stratified analysis is conducted for community based dual eligibles (n=4,703 for antidepressants, n=2,301 for antipsychotics) and nursing home dual eligibles (n=1,504 for antidepressants, n=1,011 for antipsychotics) separately. Results: For antidepressants, adjusted changes in PDC were not significant for most states, except Arkansas community based dual eligibles (p=0.00), Florida nursing home dual eligibles had a significant increase (p=0.03), New Mexico nursing home dual eligibles(p=0.01) under Part D. For antipsychotics, adjusted changes in PDC were not significant in all states except Arkansas community based dual eligibles (p=0.03) and Florida for both groups (p=0.00 for both community based dual eligibles and nursing home dual eligibles). A separate spline regression for states that had significant changes in PDC from the state-fixed effect model indicated that trends in PDC before and after Part D were not significantly different, suggesting that changes were not related to transition to Part D. Conclusions: I did not find empirical support for concerns regarding disruption of medication utilization of the dual eligible under Part D. Although states had different baseline Medicaid polices and wrap-around programs under Part D, lack of significant changes in utilization suggest that minor changes in copayments and refill/prescription limits etc. do not have large effect on medication utilization to antidepressants and antipsychotics.

Subjects/Keywords: Antidepressants; Antipsychotics; Dual Eligibles; Medicaid; Medicare Part D; Prescription Drug program

Record Details Similar Records Cite « Share

❌

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6^th Edition):

Kim, J. (2014). Medication Utilization of Dual Eligibles Before and After Medicare Part D: Cases of Antidepressants and Antipsychotics. (Doctoral Dissertation). University of Minnesota. Retrieved from http://hdl.handle.net/11299/182292

Chicago Manual of Style (16^th Edition):

Kim, Jee-Ae. “Medication Utilization of Dual Eligibles Before and After Medicare Part D: Cases of Antidepressants and Antipsychotics.” 2014. Doctoral Dissertation, University of Minnesota. Accessed February 28, 2021. http://hdl.handle.net/11299/182292.

MLA Handbook (7^th Edition):

Kim, Jee-Ae. “Medication Utilization of Dual Eligibles Before and After Medicare Part D: Cases of Antidepressants and Antipsychotics.” 2014. Web. 28 Feb 2021.

Vancouver:

Kim J. Medication Utilization of Dual Eligibles Before and After Medicare Part D: Cases of Antidepressants and Antipsychotics. [Internet] [Doctoral dissertation]. University of Minnesota; 2014. [cited 2021 Feb 28]. Available from: http://hdl.handle.net/11299/182292.

Council of Science Editors:

Kim J. Medication Utilization of Dual Eligibles Before and After Medicare Part D: Cases of Antidepressants and Antipsychotics. [Doctoral Dissertation]. University of Minnesota; 2014. Available from: http://hdl.handle.net/11299/182292

University of Hawaii – Manoa

26. Roberson, Emily Kathleen. Using pregnancy risk assessment monitoring system data to investigate prescription drug use during pregnancy in Hawaiʻi.

Degree: 2015, University of Hawaii – Manoa

URL: http://hdl.handle.net/10125/100473

►

Ph.D. University of Hawaii at Manoa 2014.

Both legal and illicit use of prescription drugs during pregnancy is thought to be increasingly common in the… (more)

▼

Ph.D. University of Hawaii at Manoa 2014.

Both legal and illicit use of prescription drugs during pregnancy is thought to be increasingly common in the state of Hawaiʻi, based on trends demonstrated elsewhere in the country and throughout the world. Prescription opioids, along with antianxiety and antidepressant medications are of special concern, both for their prevalence and for the potential risks associated with using these drugs during pregnancy. The purpose of this dissertation is to investigate prescription drug use during pregnancy in Hawaiʻi, with a focus on opioids and antianxiety and antidepressant medications. The first of three studies sought to determine the prevalence of prescription opioid drug use during pregnancy in Hawaiʻi, describe differences in prescription opioid drug use during pregnancy in Hawaiʻi by maternal demographic characteristics, and investigate possible predictors of prescription opioid drug use during pregnancy through the use of multivariable logistic regression. The second study aimed to determine whether prescription opioid use during pregnancy was associated with poorer birth outcomes among users when compared to non-users in Hawaiʻi; specifically focusing on associations between prescription opioid use during pregnancy and risk of small for gestational age, preterm, or low birth weight deliveries among women giving birth to live, singleton infants in Hawaiʻi. Study three attempted to describe the under-studied topics of anxiety and depression before, during, and after pregnancy, along with related help-seeking behaviors and treatment strategies, for which there is a scarcity of information in Hawaiʻi. Findings from the three studies covered in this dissertation confirm that use of prescription opioids and antianxiety and antidepressant medications is relatively common during pregnancy in Hawaiʻi. They also provide more detailed information on usage patterns, differences by demographic characteristics, and associated risk factors and birth and maternal health outcomes. All three also provide suggestions for future research avenues in order to more fully understand the complete landscape of prescription drug use during pregnancy in Hawaiʻi.

Subjects/Keywords: Opioids; Prescription drug use; Pregnancy; Birth outcomes; Depression; Anxiety

Record Details Similar Records Cite « Share

❌

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6^th Edition):

Roberson, E. K. (2015). Using pregnancy risk assessment monitoring system data to investigate prescription drug use during pregnancy in Hawaiʻi. (Thesis). University of Hawaii – Manoa. Retrieved from http://hdl.handle.net/10125/100473

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16^th Edition):

Roberson, Emily Kathleen. “Using pregnancy risk assessment monitoring system data to investigate prescription drug use during pregnancy in Hawaiʻi.” 2015. Thesis, University of Hawaii – Manoa. Accessed February 28, 2021. http://hdl.handle.net/10125/100473.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7^th Edition):

Roberson, Emily Kathleen. “Using pregnancy risk assessment monitoring system data to investigate prescription drug use during pregnancy in Hawaiʻi.” 2015. Web. 28 Feb 2021.

Vancouver:

Roberson EK. Using pregnancy risk assessment monitoring system data to investigate prescription drug use during pregnancy in Hawaiʻi. [Internet] [Thesis]. University of Hawaii – Manoa; 2015. [cited 2021 Feb 28]. Available from: http://hdl.handle.net/10125/100473.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Roberson EK. Using pregnancy risk assessment monitoring system data to investigate prescription drug use during pregnancy in Hawaiʻi. [Thesis]. University of Hawaii – Manoa; 2015. Available from: http://hdl.handle.net/10125/100473

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

27. Mazer-Amirshahi, Maryann. Prescription Drug Shortages: Implications for Public Health and Potential Solutions.

Degree: 2019, Erasmus University Medical Center

URL: http://hdl.handle.net/1765/116728

► markdownabstractPrescription drug shortages have reached critical levels in the United States and represent a significant threat to healthcare quality and patient safety. The increase in… (more)

Subjects/Keywords: Prescription drug shortages; public health

Record Details Similar Records Cite « Share

❌

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6^th Edition):

Mazer-Amirshahi, M. (2019). Prescription Drug Shortages: Implications for Public Health and Potential Solutions. (Doctoral Dissertation). Erasmus University Medical Center. Retrieved from http://hdl.handle.net/1765/116728

Chicago Manual of Style (16^th Edition):

Mazer-Amirshahi, Maryann. “Prescription Drug Shortages: Implications for Public Health and Potential Solutions.” 2019. Doctoral Dissertation, Erasmus University Medical Center. Accessed February 28, 2021. http://hdl.handle.net/1765/116728.

MLA Handbook (7^th Edition):

Mazer-Amirshahi, Maryann. “Prescription Drug Shortages: Implications for Public Health and Potential Solutions.” 2019. Web. 28 Feb 2021.

Vancouver:

Mazer-Amirshahi M. Prescription Drug Shortages: Implications for Public Health and Potential Solutions. [Internet] [Doctoral dissertation]. Erasmus University Medical Center; 2019. [cited 2021 Feb 28]. Available from: http://hdl.handle.net/1765/116728.

Council of Science Editors:

Mazer-Amirshahi M. Prescription Drug Shortages: Implications for Public Health and Potential Solutions. [Doctoral Dissertation]. Erasmus University Medical Center; 2019. Available from: http://hdl.handle.net/1765/116728

University of Georgia

28. Williams, Chakita Kenyotta. Applying a model of risk information seeking to a newly discovered drug risk.

Degree: 2014, University of Georgia

URL: http://hdl.handle.net/10724/28628

► Information seeking and processing behaviors among people with type 2 diabetes about a drug’s risk, such as rosiglitazone cardiovascular risk, motivated this dissertation. To my… (more)

Subjects/Keywords: Prescription drug; medication risk; risk communication; information seeking; information processing

Record Details Similar Records Cite « Share

❌

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6^th Edition):

Williams, C. K. (2014). Applying a model of risk information seeking to a newly discovered drug risk. (Thesis). University of Georgia. Retrieved from http://hdl.handle.net/10724/28628

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16^th Edition):

Williams, Chakita Kenyotta. “Applying a model of risk information seeking to a newly discovered drug risk.” 2014. Thesis, University of Georgia. Accessed February 28, 2021. http://hdl.handle.net/10724/28628.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7^th Edition):

Williams, Chakita Kenyotta. “Applying a model of risk information seeking to a newly discovered drug risk.” 2014. Web. 28 Feb 2021.

Vancouver:

Williams CK. Applying a model of risk information seeking to a newly discovered drug risk. [Internet] [Thesis]. University of Georgia; 2014. [cited 2021 Feb 28]. Available from: http://hdl.handle.net/10724/28628.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Williams CK. Applying a model of risk information seeking to a newly discovered drug risk. [Thesis]. University of Georgia; 2014. Available from: http://hdl.handle.net/10724/28628

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

University of Georgia

29. Huh, Jisu. Perceived effects, mediating influences, and behavioral outcomes of direct-to-consumer prescription drug advertising.

Degree: 2014, University of Georgia

URL: http://hdl.handle.net/10724/21069

► Direct-to-consumer prescription drug advertising (DTCAd) is a growing, yet unique form of product advertising about which research evidence is emerging. This dissertation was undertaken to… (more)

▼ Direct-to-consumer prescription drug advertising (DTCAd) is a growing, yet unique form of product advertising about which research evidence is emerging. This dissertation was undertaken to explore questions about perceived DTCAd effects and the relationships of those perceptions and other perceptual, attitudinal, and demographic variables to two specific behavioral outcomes (support for regulation and patient behaviors), using the third-person effect framework. A mail survey of 600 randomly selected adults was executed to address nine hypotheses and three research questions. 264 useable questionnaires were returned. Among other things, the research found: •The third-person DTCAd effect is a multidimensional construct. Four DTCAd-effect factors emerged from respondents’ perceptions of DTCAd effects. •Respondents believed that DTCAd had more influence on other people’s behavior than on their own behavior. •Respondents differentiated between the negative and positive DTCAd effects, and perceived negative DTCAd effects to be more pronounced in other people’s behavior than in their own behavior. •Perceived DTCAd importance, prescription drug use, perceived DTCAd credibility/informativeness, and global DTCAd attitude were negatively associated with third-person DTCAd effects. •Perceived health and DTCAd recognition were positively associated with third-person DTCAd effects. •Ability of the third-person DTCAd effect to predict support for DTCAd regulation did not vary by global DTCAd attitude. When global DTCAd attitude was controlled for, third-person DTCAd effects did not predict support for DTCAd regulation. •Older, employed, less educated respondents, who disliked DTCAd, but who perceived themselves more familiar and knowledgeable of DTCAd were more likely to support DTCAd regulation. Those who perceived DTCAd as credible were less likely to support DTCAd regulation. •The third-person effect associated with the DTCAd factor, "learning & involvement," was a significant negative predictor of patient behavior. •Perceived DTCAd importance and respondent race were significant positive predictors of patient behavior. •Ability of third-person DTCAd effects to predict DTCAd-targeted patient behavior did not vary by respondents’ global DTCAd attitudes. No matter how much the respondents liked or disliked DTCAd, those who perceived greater third-person DTCAd effects were less likely to engage in ad-targeted patient behaviors. The significance of the results is discussed relative to the research literature. Methodological imitations are presented, followed by implications for advancing DTCAd research.

Subjects/Keywords: DTC prescription drug advertising; third-person effect; advertising effects; pharmaceutical advertising

Record Details Similar Records Cite « Share

❌

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6^th Edition):

Huh, J. (2014). Perceived effects, mediating influences, and behavioral outcomes of direct-to-consumer prescription drug advertising. (Thesis). University of Georgia. Retrieved from http://hdl.handle.net/10724/21069

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16^th Edition):

Huh, Jisu. “Perceived effects, mediating influences, and behavioral outcomes of direct-to-consumer prescription drug advertising.” 2014. Thesis, University of Georgia. Accessed February 28, 2021. http://hdl.handle.net/10724/21069.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7^th Edition):

Huh, Jisu. “Perceived effects, mediating influences, and behavioral outcomes of direct-to-consumer prescription drug advertising.” 2014. Web. 28 Feb 2021.

Vancouver:

Huh J. Perceived effects, mediating influences, and behavioral outcomes of direct-to-consumer prescription drug advertising. [Internet] [Thesis]. University of Georgia; 2014. [cited 2021 Feb 28]. Available from: http://hdl.handle.net/10724/21069.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Huh J. Perceived effects, mediating influences, and behavioral outcomes of direct-to-consumer prescription drug advertising. [Thesis]. University of Georgia; 2014. Available from: http://hdl.handle.net/10724/21069

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

University of Georgia

30. Cantrell, Christopher Ron. Development and validation of risk assessment models to predict pharmacy expenditures for both commercial and medicaid populations.

Degree: 2014, University of Georgia

URL: http://hdl.handle.net/10724/21448

► Numerous risk assessment models have been developed to predict overall healthcare costs, utilization, mortality and hospital length of stay, however, there have been no models… (more)

▼ Numerous risk assessment models have been developed to predict overall healthcare costs, utilization, mortality and hospital length of stay, however, there have been no models to date developed specifically to predict prescription expenditures. The objective of this research was to empirically develop a claims-based risk assessment model to predict prescription expenditures for both a commercial and Medicaid population. The models were developed using three years, 1998 through 2000, of MEDSTAT MarketScan data (commercial) and California Medicaid data (Medicaid). Both datasets are claims-based data that include medical and pharmacy claims and enrollment information in a linkable format. The MarketScan training sample used to develop the commercial models included over 1.3 million lives after the inclusion/exclusion criteria were satisfied. The California Medicaid (MediCal) training sample used to develop the Medicaid models included over 138 thousand lives after the inclusion/exclusion criteria were satisfied. A random sample of each dataset was used to validate the models. Ordinary Least Squares (OLS) was utilized to estimate the model coefficients. The primary model for this research, the Rx Cost Model (RxCost), is a diagnostic-based model that was empirically developed using diagnostic information. Another model, the Mixed Rx Cost Model (MRxCost), is a diagnostic and drug-based model that was developed to explore the gain in predictive power of supplementing the RxCost Model with drug information. The MarketScan validation sample was utilized to compare the performance of the models developed for the commercial population to each other as well as a Demographic-only model and the commercially available DCG-HCC model. The MediCal validation sample was used to compare the performance of the models developed for the Medicaid population to each other as well as a Demographic-only model, a Demographic and Medicaid eligibility model and the CDPS model. The R-square values for the commercial RxCost Model, the MRxCost Model and the DCG-HCC using the validation sample were 0.22, 0.34 and 0.16 respectively. The R-square values for the Medicaid RxCost Model, the MRxCost Model and the CDPS using the validation sample were 0.24, 0.30 and 0.04 respectively. The RxCost Model for both the commercial and Medicaid population performed better then the DCG-HCC and the CDPS in terms of R-square. The MRxCost Model for each population also performed well and resulted in a substantial gain of predictive power in terms of R-square.

Subjects/Keywords: Risk Assessment; Risk Adjustment; Prescription Cost; Drug Cost; Risk Models

Record Details Similar Records Cite « Share

❌

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6^th Edition):

Cantrell, C. R. (2014). Development and validation of risk assessment models to predict pharmacy expenditures for both commercial and medicaid populations. (Thesis). University of Georgia. Retrieved from http://hdl.handle.net/10724/21448

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16^th Edition):

Cantrell, Christopher Ron. “Development and validation of risk assessment models to predict pharmacy expenditures for both commercial and medicaid populations.” 2014. Thesis, University of Georgia. Accessed February 28, 2021. http://hdl.handle.net/10724/21448.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7^th Edition):

Cantrell, Christopher Ron. “Development and validation of risk assessment models to predict pharmacy expenditures for both commercial and medicaid populations.” 2014. Web. 28 Feb 2021.

Vancouver:

Cantrell CR. Development and validation of risk assessment models to predict pharmacy expenditures for both commercial and medicaid populations. [Internet] [Thesis]. University of Georgia; 2014. [cited 2021 Feb 28]. Available from: http://hdl.handle.net/10724/21448.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Cantrell CR. Development and validation of risk assessment models to predict pharmacy expenditures for both commercial and medicaid populations. [Thesis]. University of Georgia; 2014. Available from: http://hdl.handle.net/10724/21448

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

		in
And / Or
		in
And / Or
		in
And / Or
		in

Open Access Theses and Dissertations